At Abiomed's European headquarters in Aachen, Germany, Impella heart pumps have been developed and produced for more than 20 years to stabilize and recover the human heart. The single access procedure ...
HACKENSACK, N.J., Oct. 28, 2019 /PRNewswire/ -- On October 16, 2019, Hackensack Meridian Health's Hackensack University Medical Center performed its first cardiovascular surgery procedures using a new ...
Over 3,000 U.S. Patients Have Received Higher Flow Impella CP DANVERS, Mass., (GLOBE NEWSWIRE) -- Abiomed, Inc., a leading provider of breakthrough heart support technologies, today reported that ...
Abiomed Inc.ABMD recently announced that its Impella 2.5 heart pump has received FDA Pre-Market Approval (PMA) for use in high risk percutaneous coronary intervention (PCI) procedures. Notably, ...
The Heart Hospital of Northwest Texas Healthcare System has been recognized by Abiomed for its achievement of 200 Impella procedures, according to a news release. This life-changing procedure has ...
Sportschosun on MSN
Chonnam National University Hospital succeeded in introducing Impella for the first time in the coun...
Chonnam National University Hospital succeeded in introducing Impella for the first time in the coun... Chonnam National ...
Impella 2.5 is the Only FDA-Approved Percutaneous Hemodynamic Support Device Determined to be Safe and Effective for the High Risk PCI Indication DANVERS, MA – Abiomed, Inc., a leading provider of ...
Ocala Regional Medical Center has introduced new minimally invasive technology that helps patients' heart pump blood during surgery. Ocala Health — which includes the medical center and West Marion ...
DANVERS, Mass.--(BUSINESS WIRE)--The versatility and innovation of Abiomed’s (NASDAQ: ABMD) Impella 5.5 with SmartAssist, a minimally-invasive forward flow heart pump, is leading to continued adoption ...
A pricey high-tech pump that maintains blood flow during heart procedures could be more dangerous to patients than its low-tech predecessor, a pair of recent studies finds. The Impella device is ...
In this wide-ranging interview, Fool contributor Brian Feroldi chats with CEO Michael Minogue about the medical device company's competitive landscape, growth potential, valuation, and more. So what's ...
AACHEN, Germany--(BUSINESS WIRE)--Following consultation with its notified body, MEDCERT GmbH, Abiomed is introducing the single access procedure with Impella CP introducer sheaths for the treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback